HealthCare Institute of New Jersey Statement on WTO TRIPS Waiver Decision
Trenton, March 2, 2024 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning
Trenton, March 2, 2024 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning
Trenton, February 8, 2024 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning
Trenton, December 11, 2023 ― Chris Lepore, Chair of the Board of Trustees of the HealthCare Institute of New Jersey (HINJ) and Vice President, U.S.
Trenton, August 29, 2023 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer. The storied achievements of our life sciences sector – our biopharmaceutical, biotech, diagnostic
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer Among our many learnings from the COVID-19 pandemic is that a robust and
Steve Issenman
Senior V.P.
732-729-9621
issenman@hinj.org